Crisdesalazine
Crisdesalazine (AAD-2004, AAD2004) is a derivative of aspirin that inhibits microsomal PGE (2) synthase-1 (mPGES-1) activity in response to both LPS-treated BV2 cell with IC50 of 230 nM and recombinant human mPGES-1 protein with IC50 of 249 nM in vitro.
Product Specifications
CAS Number
927685-43-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
325.287
Molecular Formula
C16H14F3NO3
Notes
Research use only, not for human use.
Receptor
PGE synthase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
173829 250 Roll (250 Label (s) x 1 Roll)
M6-31-7546 Pre-sized Labels for Printers
Sign In for Pricing
View Details 
OR1074372-01 50 mg
(S) -2- ((((9H-Fluoren-9-yl) methoxy) carbonyl) amino) -4- (((2R,3R,4R,5S,6R) -3-acetamido-4,5-diacetoxy-6- (acetoxymethyl) tetrahydro-2H-pyran-2-yl) amino) -4-oxobutanoic acid
Sign In for Pricing
View Details OR1074372-02 100 mg
(S) -2- ((((9H-Fluoren-9-yl) methoxy) carbonyl) amino) -4- (((2R,3R,4R,5S,6R) -3-acetamido-4,5-diacetoxy-6- (acetoxymethyl) tetrahydro-2H-pyran-2-yl) amino) -4-oxobutanoic acid
Sign In for Pricing
View Details